4CPS-105 Blinatumomab for the treatment of the relapse b-precursor acute lymphoblastic leukaemia in a paediatric patient: a case report

BACKGROUND: Paediatric patients with relapsed B-precursor acute lymphoblastic leukaemia (ALL) after haematopoietic stem cell transplantation (HSCT) have a poor prognosis and need to achieve another haematologic remission or very low or negative minimal residual disease (MRD) before proceeding to a s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Hosp Pharm
Egile Nagusiak: Valencia, JC del Río, Pelayo, MRuiz de Villegas Garcia, Bermejo, RTamayo, Castillo, I Muñoz
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2018
Gaiak:
Section 4: Clinical pharmacy services
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535816/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.196
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak